Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tianzhi Granule in Mild to Moderate Vascular Dementia
NCT02453932Phase 3Completed
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Oct 2013
- Primary completion
- May 2017
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Tianzhi granule in vascular dementia (3 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoints: Vascular Dementia Assessment Scale-Cognitive Subscale at 24 weeks and Clinician's Interview-Based Impression of Change-Plus carer Interview at 24 weeks. Started Oct 2013; status: completed.
02
Drugs
Tianzhi granule
03
Conditions
vascular dementia
Beyond the preview
Go deeper on NCT02453932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02453932.